x

Search for a clinical trial

* (*) mandatory field

208 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Recruiting trial
Ongoing trial
Phase II Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma
Universitair Ziekenhuis Brussel - UZ Brussel
Universitair Ziekenhuis Brussel (UZ Brussel)

GERMANY

Hamburg
HAMBURG

Ongoing trial
Phase 3b Study for Management of Ocular Side Effects in Subjects With EGFR-amplified Glioblastoma Receiving Depatuxizumab Mafodotin (ABT-414) -DE-
Hubertus Wald Tumorzentrum/ Universitäres Cancer Center (UCCH)
Comprehensive Cancer Center (CCC) Hamburg

UNITED KINGDOM

Greater London
LONDON

FINLAND

Finland
HELSINKI

BNCT to treat glioma that has progressed following radiotherapy
HUCH - Helsinki University Central Hospital
Department of Oncology

FRANCE

AUVERGNE-RHONE-ALPES
BRON

Recruiting trial
Ongoing trial
Randomized, Prospective, Multicenter Blinding Singles With Arm A and Arm B Innovative Strategy Strategy Conventional (Phase III) - FR
CHU de Lyon HCL - GH Est-Hôpital Neurologique P. Wertheimer
Neurochirurgie B - Unité multidisciplinaire de Chirurgie Tumorale de la base du Crâne

FRANCE

BRETAGNE
RENNES

FRANCE

ILE-DE-FRANCE
BOBIGNY

A Phase II multicenter study of immunotherapy with CpG-ODN in patients with glioblastoma -Terminated -
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
Service de Neurologie

FRANCE

ILE-DE-FRANCE
BOBIGNY

Randomized Phase III Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma - Terminated -
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
Service de Neurologie

FRANCE

ILE-DE-FRANCE
BOBIGNY

Glivec - Hydrea in recurrent glioblastoma (Phase II) - Terminated -
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
Service de Neurologie

FRANCE

ILE-DE-FRANCE
BOBIGNY

Recruiting trial
Radiotherapy and Temozolomide with or without Avastin for treatment of de novo glioblastoma (Phase III)
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
Service de Neurologie

FRANCE

ILE-DE-FRANCE
BOBIGNY

FRANCE

ILE-DE-FRANCE
PARIS

EORTC protocol 26083 : Randomized phase II of CCNU (Lomustine) versus CCNU (Lomustine) - dasatinib in patients with recurrent glioblastoma
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Unité Fonctionnelle Epilepsie

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Multicentric Randomized Phase II: Immunotherapy With CpG-ODN in Malignant Glioblastoma
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Consultation de Neurochirurgie

FRANCE

ILE-DE-FRANCE
PARIS

Chemotherapy study of temozolomide-bevacizumab treatment of supratentorial glioblastoma patients more than 70 years old with altered functional state (Phase II).
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Service de Neurologie 2 : Unité d'Onco-Neurologie

FRANCE

ILE-DE-FRANCE
PARIS

Phase III study chemotherapy vs radiotherapy in low-grade glioma
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Service de Neurologie 2 : Unité d'Onco-Neurologie

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
A Prospective, Multi-center Phase III Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients With Newly Diagnosed Glioblastoma Multiforme
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Service de Neurologie 2 : Unité d'Onco-Neurologie

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
ONCOVIRAC : Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients (Phase I-II)
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Service de Neurologie 2 : Unité d'Onco-Neurologie

FRANCE

ILE-DE-FRANCE
PARIS

Phase I/II study of S49076, a multi-target inhibitor of c-MET, AXL, FGFR in combination with bevacizumab in patients with recurrent glioblastoma multiforme - FR
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Service de Neurologie 2 : Unité d'Onco-Neurologie

FRANCE

OCCITANIE
TOULOUSE

PhaseI-II trial to assess the radiosensitizing effect of Zarnestra in patients with glioblastoma multiforme
IUCT Oncopole - CLCC Institut Claudius Regaud
Département de radiothérapie

FRANCE

OCCITANIE
TOULOUSE

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

A randomized multicentric phase II trial immunotherapy of de novo glioblastoma by CpG-ODN
CHU de Marseille - Hôpital de la Timone
Service de Neuro-oncologie

FRANCE

PROVENCE-ALPES-COTE D'AZUR
NICE

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Bayern
MÜNCHEN

Recruiting trial
Ongoing trial
GlioCave/NOA17: Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma (Phase 2) - DE
Klinikum rechts der Isar der Technischen Universität München
Klinik und Poliklinik für RadioOnkologie und Strahlentherapie

GERMANY

Berlin
ADDRESS: NOT PROVIDED - DE

GERMANY

Berlin
BERLIN

Recruiting trial
Ongoing trial
The C-GBM Study: Prospective controlled phase II trial of Cabazitaxel in patients with Temozolomide refractory Glioblastoma Multiforme - DE
Charité - Universitätsmedizin Berlin (CVK)
Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie

ITALY

LOMBARDIA
RANICA

Multicenter, randomized, non-comparative, open-label phase II trial on the efficacy of Ortataxel and Fotemustine in recurrent glioblastoma
Istituto di Ricerche Farmacologiche Mario Negri
Unità di Ricerca Traslazionale in Oncologia Ginecologica

NETHERLANDS

Limburg
MAASTRICHT

NETHERLANDS

Noord-Holland
AMSTERDAM

NETHERLANDS

Zuid-Holland
ROTTERDAM

SPAIN

Cataluña
BARCELONA

SPAIN

Navarra
PAMPLONA

Phase II study of neoadjuvant nivolumab in patients with glioblastoma multiforme - ES (completed)
CIMA - Centro de Investigación Médica Aplicada
Área de Terapia Génica y Hepatología

SWITZERLAND

Suisse Alémanique
ZÜRICH

Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma (ARTE)
University Hospital Zurich
Department of Neurology

UNITED KINGDOM

Greater London
LONDON

ITALY

LOMBARDIA
MILANO

Recruiting trial
Ongoing trial
Phase II, open label, monocentric, uncontrolled, non randomized clinical trial on Sodium Fluorescein for Surgery of High Grade Gliomas
Fondazione IRCCS Istituto Neurologico "Carlo Besta"
UOC Neurochirurgia 2 - Neurochirurgia Vascolare

FRANCE

AUVERGNE-RHONE-ALPES
GRENOBLE

GERMANY

Bayern
REGENSBURG

GERMANY

Nordrhein-Westfalen
BONN

FRANCE

AUVERGNE-RHONE-ALPES
LYON

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
A Study Evaluating Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe Asthenia. A Phase III Double-blind Randomized Placebo-controlled Trial
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Unité Fonctionnelle Epilepsie

FRANCE

ILE-DE-FRANCE
PARIS

DXA : A Study Evaluating Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe Asthenia. A Phase III Double-blind Randomized Placebo-controlled Trial
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Service de Neurologie 2 : Unité d'Onco-Neurologie

FRANCE

ILE-DE-FRANCE
VILLEJUIF

Recruiting trial
Ongoing trial
BIOMEDE: Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication (Phase II) - FR
CLCC Institut Gustave Roussy
Département de Cancérologie de l'enfant et de l'adolescent

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

GERMANY

Niedersachsen
GÖTTINGEN

IRELAND

County Dublin
DUBLIN

A Phase II Multi-Centre Study of Concomitant and Prolonged Adjuvant Temozolomide With Radiotherapy in Diffuse Pontine Gliomas - IE
Our Lady's Children's Hospital
National Oncology/ Bone Marrow Transplant Centre and Haematology Department

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

CNS 2007 04: A Phase II Multi-Centre Study of Concomitant and Prolonged Adjuvant Temozolomide With Radiotherapy in Diffuse Pontine Gliomas - UK (Completed)
The Great North Children's Hospital, Royal Victoria Infirmary
Sir James Spence Institute of Child Health

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Ongoing trial
STEP: Sorafenib Long Term Extension Program - BE
Cliniques Universitaires UCL Saint-Luc
Pneumologie_Oncologie thoracique

Multinational clinical trial(s)

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
ADDRESS: NOT PROVIDED - BE

GERMANY

Baden-Württemberg
TÜBINGEN